Biden’s got pharma’s back in global pandemic treaty negotiations


… U.S. negotiators working on a global treaty that aims to guide the world’s response whenever a new deadly pathogen emerges have rejected proposals to loosen patent protections, a step that could enable developing countries to quickly make their own versions of the vaccines and drugs. For those countries and their advocates, it’s a striking stance — given what happened after Covid arrived: They shared data about new variants only to see the rich world hoard most of the vaccines. “There’s a contradiction, [an] enormous amount of hypocrisy,” said James Love, director of Knowledge Ecology International, who advocates for wider access to health products, of the Biden administration’s position. Love said the U.S. has used some of the same measures developing countries have proposed to limit intellectual property rights in the production of Covid vaccines at home.